Skip to content

A Dutch Prospective, Multi-disciplinary, Multicentric And Randomized Study To Compare Minimally Invasive Reduction and Fixation Using The Kyphx-System And Radiopaque PMMA Cement To Non surgical Therapy Alone For The Treatment of Painful, Acute Osteopenic Vertebral Body Compression Fractures

A Dutch Prospective, Multi-disciplinary, Multicentric And Randomized Study To Compare Minimally Invasive Reduction and Fixation Using The Kyphx-System And Radiopaque PMMA Cement To Non surgical Therapy Alone For The Treatment of Painful, Acute Osteopenic Vertebral Body Compression Fractures - ECON study

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30930
Enrollment
240
Registered
2007-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteopenia - porous bone

Interventions

Patients in the non-operative arm (amount: 80) will receive medical treatment and other non-surgical treatments as back braces and physiotherapy. Patients in the balloon kypholasty arm (amount:160) w

Sponsors

Hilversum Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Minimum of one and maximum of three painful, acute (edema present on MRI obtained within a one month period prior to enrolment) vertebral body compression fractures due to osteopenia arising from osteoporosis, multiple myeloma or osteolytic metastatic tumors. -Pre-treatment VAS score of 4 or more on scale 0 (no pain) - 10 (worst imaginable pain) -21 years of age or older -balloon kyphoplasty is technically feasible -a signed Informed constent has been obtained from the patient

Exclusion criteria

Exclusion criteria: -pedicle fractures -pre-existing neurological deficit or radicular pain -Spinal cord compression or canal compromise requiring decompression -Disabling back pain secondary to causes other than the fractures -pre-existing contraindications to surgery in general, to MRI or known allergy

Design outcomes

Primary

MeasureTime frame
The change in quality of life as measured by the EQ-5D at 7 days compared to at baseline.

Secondary

MeasureTime frame
Following variables will be compared to at baseline: Pain using the VAS score (at 7days, 6 weeks, 4 & 12 months), EQ-5D (at 6 weeks and 4 & 12 months), Qualeffo (at 6 weeks adn 12 months) and an economic questionnaire (at 4 & 12 months)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)